Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Zakrzewicz, M. Hecker, M. George, J. Wilhelm, W. Seeger, H. Ghofrani, O. Eickelberg (Giessen, Germany). Chemokine (C-C motif) ligand (CCL)-2 regulation by IL-13 in pulmonary arterial hypertension (PAH). Eur Respir J 2007; 30: Suppl. 51, 489

Member's Comments

No comment yet.

Related content which might interest you: Fractalkine and its receptor (CX3CR1) in primary pulmonary hypertension (PPH) Source: Eur Respir J 2001; 18: Suppl. 33, 2s Year: 2001 Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21 Source: Eur Respir J 2007; 29: 1082-1093 Year: 2007 The interleukin 13 receptor system is altered in pulmonary arterial hypertension Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006 Deletion in macrophage chemokine receptor gene (CCR5) in children with bronchial asthma (BA) Source: Eur Respir J 2001; 18: Suppl. 33, 450s Year: 2001 C-C chemokine receptor 2 gene polymorphism V64I and C-C chemokine receptor 5 gene polymorphism Δ32 in pulmonary sarcoidosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 520s Year: 2006 A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation Source: Eur Respir J 2008; 31: 783-789 Year: 2008 A possible role for toll-like receptor (TLR) 5 in fibrotic pulmonary sarcoidosis Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis Source: Eur Respir J 2011; 38: 1136-1144 Year: 2011 Arterial concentration of macrophage migration inhibitory factor (MIF) increases with exercise in patients with pulmonary hypertension (PH) Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Expression on peripheral blood (PB) and induced sputum (IS) neutrophils (N) of the IL-8 receptors CXCR1 and CXCR2. Comparison between neutrophilic asthma and COPD Source: Annual Congress 2003 - From gene to breath analysis in airway disorders Year: 2003 CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 25: 701-707 Year: 2005 LSC Abstract – Toll-like receptor 4 (TLR4) in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2015 – IPF pathogenesis Year: 2015 CC and C chemokine expression in pulmonary sarcoidosis Source: Eur Respir J 2002; 20: 1206-1212 Year: 2002 Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Upregulation of interleukin 13 receptor alpha 2 (IL-13RA2) expression in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005 C-C chemokine receptor 2 gene polymorphism V64I and CCR2 expression on T lymphocytes in pulmonary sarcoidosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Monocyte chemotactic protein-1 (MCP-1) synthesis and function in pulmonary artery smooth muscle cells (PA-SMCs) from patients with idiopathic pulmonary hypertension (IPH) Source: Eur Respir J 2004; 24: Suppl. 48, 436s Year: 2004 Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006 CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis Source: Eur Respir J 2009; 34: 676 Year: 2009